These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21372302)

  • 1. Timing and dose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction.
    Sposito AC; Santos SN; de Faria EC; Abdalla DS; da Silva LP; Soares AA; Japiassú AV; Quinaglia e Silva JC; Ramires JA; Coelho OR
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1240-6. PubMed ID: 21372302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
    Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
    J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal.
    Sposito AC; Carvalho LS; Cintra RM; Araújo AL; Ono AH; Andrade JM; Coelho OR; Quinaglia e Silva JC;
    Atherosclerosis; 2009 Nov; 207(1):191-4. PubMed ID: 19464010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register.
    Danchin N; Fauchier L; Marijon E; Barnay C; Furber A; Mabo P; Bernard P; Blanc JJ; Jouven X; Le Heuzey JY; Charbonnier B; Ferrières J; Simon T;
    Heart; 2010 Nov; 96(22):1809-14. PubMed ID: 20965993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome.
    Chyrchel M; Dudek D; Rzeszutko L; Dziewierz A; Chyrchel B; Rakowski T; Dubiel JS
    Cardiovasc Revasc Med; 2011; 12(1):2-9. PubMed ID: 21241965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial).
    Pedersen TR; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Lindahl C; Szarek M
    Am J Cardiol; 2010 Aug; 106(3):354-9. PubMed ID: 20643245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.
    Bauersachs J; Hiss K; Fraccarollo D; Laufs U; Ruetten H
    Cardiovasc Res; 2006 Dec; 72(3):438-46. PubMed ID: 17026973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced creatine kinase release with statin use at the time of myocardial infarction.
    Bybee KA; Kopecky SL; Williams BA; Murphy JG; Scott Wright R
    Int J Cardiol; 2004 Sep; 96(3):461-6. PubMed ID: 15301900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways.
    de Sotomayor MA; Pérez-Guerrero C; Herrrera MD; Jimenez L; Marín R; Marhuenda E; Andriantsitohaina R
    Br J Pharmacol; 2005 Dec; 146(8):1130-8. PubMed ID: 16231003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
    Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
    Tousoulis D; Antoniades C; Vassiliadou C; Toutouza M; Pitsavos C; Tentolouris C; Trikas A; Stefanadis C
    Eur J Heart Fail; 2005 Dec; 7(7):1126-32. PubMed ID: 16051518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease.
    Dai YL; Luk TH; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Tam S; Fong B; Lau CP; Tse HF
    Cardiovasc Toxicol; 2010 Jun; 10(2):130-8. PubMed ID: 20383667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensive lipid lowering statin therapy immediately after acute coronary syndrome].
    Kovanen PT; Pentikäinen MO
    Duodecim; 2005; 121(10):1029-32. PubMed ID: 15999505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].
    Hanss R; Bein B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):246-52; quiz 253. PubMed ID: 20387182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
    Spencer FA; Fonarow GC; Frederick PD; Wright RS; Every N; Goldberg RJ; Gore JM; Dong W; Becker RC; French W;
    Arch Intern Med; 2004 Oct; 164(19):2162-8. PubMed ID: 15505131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.